Ligand Pharmaceuticals Inc. (LGND) is a publicly traded Healthcare sector company. As of September 9, 2026, LGND trades at $287.90 with a market cap of $5.69B and a P/E ratio of 28.51. LGND moved +1.05% today. Year to date, LGND is +52.76%; over the trailing twelve months it is +74.14%. Its 52-week range spans $93.58 to $326.63. Analyst consensus is strong buy with an average price target of $350.86. Rallies surfaces LGND's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for LGND combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $287.90 |
| Market Cap | $5.69B |
| P/E Ratio | 28.51 |
| EPS | $10.07 |
| Dividend Yield | 0.08% |
| 52-Week High | $326.63 |
| 52-Week Low | $93.58 |
| Volume | 197.08K |
| Avg Volume | 0 |
| Revenue (TTM) | $290.54M |
| Net Income | $197.22M |
| Gross Margin | 0.00% |
8 analysts cover LGND: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $350.86.